![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Pfizer | LSE:PFZ | London | Ordinary Share | COM STK USD0.05 |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 18.78 | 0.00 | 01:00:00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
0 | 0 | N/A | 0 |
TIDMPFZ
RNS Number : 6649G
JPMorgan Asset Management
23 November 2015
AMENDMENT
FORM 8.3
IRISH TAKEOVER PANEL
DISCLOSURE UNDER RULE 8.3 OF THE IRISH TAKEOVER PANEL ACT, 1997, TAKEOVER RULES, 2007 (AS AMENDED)
DEALINGS BY PERSONS WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR MORE
1. KEY INFORMATION Name of person dealing JPMorgan Asset Management (Note 1) -------------------------------------- -------------------------- Company dealt in Pfizer Inc. -------------------------------------- -------------------------- Class of relevant security Ordinary Shares to which the dealings being disclosed relate (Note 2) -------------------------------------- -------------------------- Date of dealing 19 November 2015 -------------------------------------- -------------------------- 2. INTERESTS AND SHORT POSITIONS
(a) Interests and short positions (following dealing) in the class of relevant security dealt in (Note 3)
Long Short --------------------------------- -------------------- ------------- Number (%) Number (%) --------------------------------- ------------- ----- ------- ---- 87,272,532 (1) Relevant securities * 1.42 --------------------------------- ------------- ----- ------- ---- (2) Derivatives (other than options) 208,388 0.00 --------------------------------- ------------- ----- ------- ---- (3) Options and agreements to purchase/sell --------------------------------- ------------- ----- ------- ---- 87,480,920 Total * 1.42 --------------------------------- ------------- ----- ------- ----
*In addition to the dealings in section 3, there is a reduction in the holding of 184 shares due to a transfer.
(b) Interests and short positions in relevant securities of the company, other than the class dealt in (Note 3)
Class of relevant security: Long Short -------------------------------- ------------- ------------- Number (%) Number (%) -------------------------------- ------- ---- ------- ---- (1) Relevant securities -------------------------------- ------- ---- ------- ---- (2) Derivatives (other than options) -------------------------------- ------- ---- ------- ---- (3) Options and agreements to purchase/sell -------------------------------- ------- ---- ------- ---- Total -------------------------------- ------- ---- ------- ---- 3. DEALINGS (Note 4) (a) Purchases and sales Purchase/sale Number of relevant Price per unit securities (USD) -------------- ------------------- --------------- Purchase 118,756 32.1650 USD Purchase 220 32.1777 USD Purchase 53 32.2472 USD Purchase 41 32.2473 USD Purchase 110 32.2500 USD Purchase 329 32.2565 USD Purchase 75 32.3000USD Purchase 7 32.3100 USD Purchase 549 32.3600 USD Purchase 314 32.4680 USD Purchase 227,840 32.8023 USD Sale 492 31.9990 USD Sale 162 32.0200 USD Sale 111 32.0890 USD Sale 106,200 32.1159 USD Sale 4 32.1250 USD Sale 3 32.1270 USD Sale 20 32.1280 USD Sale 50 32.1290 USD Sale 4 32.1300 USD Sale 79,800 32.1450 USD Sale 551 32.1480 USD Sale 2,620 32.1540 USD Sale 13,500 32.1932 USD Sale 44 32.2410 USD Sale 63 32.2420 USD Sale 31 32.2450 USD Sale 30 32.2590 USD Sale 148 32.2690 USD Sale 20 32.2700 USD Sale 10 32.2780 USD Sale 27 32.2790 USD Sale 36,932 32.2920 USD Sale 38 32.2980 USD Sale 89 32.2990 USD Sale 29 32.3000 USD Sale 166,491 32.3111 USD Sale 50,784 32.3270 USD Sale 130 32.4890 USD Sale 14 32.4900 USD Sale 176,300 32.6332 USD Sale 44 32.6690 USD Sale 25 32.8200 USD Sale 2,040 32.8499 USD Sale 15 32.8900 USD Sale 252 32.8910 USD Sale 112 32.8920 USD Sale 4 32.8930 USD -------------- ------------------- --------------- (b) Derivatives transactions (other than options transactions) Product name, Nature of transaction Number of relevant Price per unit e.g. CFD (Note 6) securities (Note (Note 5) 7) -------------- ---------------------- ------------------- --------------- (c) Options transactions in respect of existing relevant securities (i) Writing, selling, purchasing or varying Product name, Writing, Number of Exercise Type, Expiry Option e.g. call selling, securities price e.g. American, date money option purchasing, to which European paid/received varying the option etc. per unit etc. relates (Note (Note 5) 7) -------------- ------------- --------------- --------- ---------------- ------- --------------- (ii) Exercising Product name, e.g. Number of securities Exercise price per call option unit (Note 5) ------------------- --------------------- ------------------- (d) Other dealings (including transactions in respect of new securities) (Note 4) Nature of transaction Details Price per unit (if (Note 8) applicable) (Note 5) ---------------------- -------- ------------------- 4. OTHER INFORMATION
Agreements, arrangements or understandings relating to options or derivatives
Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form or relating to the voting rights or future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated. ------------------------------------------------------------- Is a Supplemental Form 8 attached? NO (Note 9) Date of disclosure 23 November 2015 --------------------------------------------- ---------------------- Contact name Evangelos Galiatsatos --------------------------------------------- ---------------------- Telephone number 0207 742 6148 --------------------------------------------- ---------------------- If a connected EFM, name of offeree/offeror N/A with which connected --------------------------------------------- ---------------------- If a connected EFM, state nature N/A of connection (Note 10) --------------------------------------------- ----------------------
The Notes on Form 8.3 can be viewed on the Panel's website at www.irishtakeoverpanel.ie.
This information is provided by RNS
The company news service from the London Stock Exchange
END
ISEBJBATMBJTBMA
(END) Dow Jones Newswires
November 23, 2015 10:34 ET (15:34 GMT)
1 Year Pfizer Chart |
1 Month Pfizer Chart |
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions